 |
C1 esterase inhibitor (human) |
|---|---|
| Trade Name | |
| Orphan Indication | Treatment and prevention of angioedema caused by C1-esterase inhibitor deficiency |
| USA Market Approval | USA |
| USA Designation Date | 1996-08-21 00:00:00 |
| Sponsor | Alpha Therapeutic Corporation;5555 Valley Boulevard;Los Angeles, California, 90032 |
